Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder

[1]  J. Ryan,et al.  Analytical Review , 2020, 1789.

[2]  In Kyoon Lyoo,et al.  Brain metabolic alterations in medication-free patients with bipolar disorder. , 2004, Archives of general psychiatry.

[3]  N. Kato,et al.  Reduced intracellular pH in the basal ganglia and whole brain measured by 31P‐MRS in bipolar disorder , 2004, Psychiatry and clinical neurosciences.

[4]  V. Arolt,et al.  Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression , 2003, Psychological Medicine.

[5]  Frederick K Goodwin,et al.  Suicide risk in bipolar disorder during treatment with lithium and divalproex. , 2003, JAMA.

[6]  C. Hanstock,et al.  Effects of chronic lithium and sodium valproate on concentrations of brain amino acids , 2003, European Neuropsychopharmacology.

[7]  In Kyoon Lyoo,et al.  Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy. , 2003, Bipolar disorders.

[8]  Morris H. Baslow,et al.  N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function , 2003, Neurochemical Research.

[9]  D. Dunner.  Drug interactions of lithium and other antimanic/mood-stabilizing medications. , 2003, The Journal of clinical psychiatry.

[10]  R. Baldessarini,et al.  Lithium treatment and suicide risk in major affective disorders: update and new findings. , 2003, The Journal of clinical psychiatry.

[11]  Martin Fiebich,et al.  Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients , 2003, Psychiatry Research: Neuroimaging.

[12]  J. Krystal,et al.  Increased cortical GABA concentrations in depressed patients receiving ECT. , 2003, The American journal of psychiatry.

[13]  C. Hanstock,et al.  Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients , 2003, International clinical psychopharmacology.

[14]  G. Dawson,et al.  Regional brain chemical alterations in young children with autism spectrum disorder , 2003, Neurology.

[15]  S. Strakowski,et al.  Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. , 2002, Bipolar disorders.

[16]  C. Hanstock,et al.  Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients , 2002, Human psychopharmacology.

[17]  P. S. Klein,et al.  Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. , 2002, Pharmacology & therapeutics.

[18]  D. Kupfer,et al.  Increased gray matter volume in lithium-treated bipolar disorder patients , 2002, Neuroscience Letters.

[19]  J. Alonso,et al.  Different dependence of lithium and valproate on PI3K/PKB pathway. , 2002, Bipolar disorders.

[20]  T. Serikawa,et al.  The Effects of Lithium Chloride and Other Substances on Levels of Brain N-Acetyl-L-Aspartic Acid in Canavan Disease-Like Rats , 2002, Neurochemical Research.

[21]  M. Frye,et al.  Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? , 2002, Journal of affective disorders.

[22]  M. Baslow,et al.  Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system An analytical review , 2002, Neurochemistry International.

[23]  P. Renshaw,et al.  Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine , 2002, Biological Psychiatry.

[24]  Jan Scott,et al.  Treatment non‐adherence in affective disorders , 2002, Acta psychiatrica Scandinavica.

[25]  P. Renshaw,et al.  Magnetic resonance spectroscopy: current and future applications in psychiatric research , 2002, Biological Psychiatry.

[26]  P. Renshaw,et al.  Biexponential transverse relaxation (T2) of the proton MRS creatine resonance in human brain , 2002, Magnetic resonance in medicine.

[27]  P. Renshaw,et al.  Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled 31P magnetic resonance spectroscopy study , 2001, Biological Psychiatry.

[28]  L. Gjerstad,et al.  Up‐regulation of hippocampal glutamate transport during chronic treatment with sodium valproate , 2001, Journal of neurochemistry.

[29]  J. McCracken,et al.  Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder , 2001, Neuropsychopharmacology.

[30]  J. Glennon,et al.  Differential effects of acute and short‐term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat , 2000, Synapse.

[31]  Rena Li,et al.  A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency , 2000, Neuroscience Letters.

[32]  C. Hanstock,et al.  Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain , 2000, Brain Research.

[33]  G. Moore,et al.  Lithium-induced increase in human brain grey matter , 2000, The Lancet.

[34]  A. Stoll,et al.  Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. , 2000, Bipolar disorders.

[35]  H. Manji,et al.  Signaling: cellular insights into the pathophysiology of bipolar disorder , 2000, Biological Psychiatry.

[36]  M. Keshavan,et al.  Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  M. Baslow,et al.  Functions of N‐Acetyl‐l‐Aspartate and N‐Acetyl‐l‐Aspartylglutamate in the Vertebrate Brain , 2000, Journal of neurochemistry.

[38]  Guang Chen,et al.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? , 2000, Biological Psychiatry.

[39]  M. Murray,et al.  Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate , 2000 .

[40]  S. Rapoport,et al.  Brain myo‐inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment , 2000, Neuroreport.

[41]  S. Posse,et al.  Modeling brain compartmental lactate response to metabolic challenge: a feasibility study , 2000, Psychiatry Research: Neuroimaging.

[42]  C. Hanstock,et al.  Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS , 1999, Biological Psychiatry.

[43]  J. M. Fuentes,et al.  Different mechanisms of protection against apoptosis by valproate and Li+. , 1999, European journal of biochemistry.

[44]  J. Parrish,et al.  Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. , 1999, The American journal of psychiatry.

[45]  J. Lieberman,et al.  MRI changes during water loading in patients with polydipsia and intermittent hyponatremia. , 1999, The American journal of psychiatry.

[46]  C. Hanstock,et al.  Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. , 1999, Journal of psychiatry & neuroscience : JPN.

[47]  N. Kato,et al.  Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder , 1999, Psychological Medicine.

[48]  R. Mattson,et al.  Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures , 1999, Seizure.

[49]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[50]  W. Brooks,et al.  Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.

[51]  H. Isoda,et al.  Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder , 1998, Psychiatry Research: Neuroimaging.

[52]  C. Vargas,et al.  Dissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluid. , 1998, General pharmacology.

[53]  C Yuan,et al.  In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI) , 1997, Magnetic resonance in medicine.

[54]  J. Dixon,et al.  The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Weissman,et al.  Cross-national epidemiology of major depression and bipolar disorder. , 1996, JAMA.

[56]  T. Inubushi,et al.  Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. , 1996, Journal of psychiatry & neuroscience : JPN.

[57]  R. Parthasarathy,et al.  Myo-Inositol Monophosphatase: Diverse Effects of Lithium, Carbamazepine, and Valproate , 1995, Neuropsychopharmacology.

[58]  P. Narayana,et al.  Relative Concentrations of Proton MR Visible Neurochemicals in Gray and White Matter in Human Brain , 1995, Magnetic resonance in medicine.

[59]  Rolf Gruetter,et al.  Localized 13C NMR Spectroscopy in the Human Brain of Amino Acid Labeling from d‐[1‐13C]Glucose , 1994, Journal of neurochemistry.

[60]  J. Baraban.  Toward a crystal-clear view of lithium's site of action. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Jope,et al.  Lithium and brain signal transduction systems. , 1994, Biochemical pharmacology.

[62]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[63]  T. Inubushi,et al.  Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. , 1992, Journal of affective disorders.

[64]  A. Stoll,et al.  The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: An in vivo proton magnetic resonance spectroscopy study , 1992, Biological Psychiatry.

[65]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[66]  W. Sherman,et al.  Chronically Administered Lithium Alters Neither myo‐Inositol Monophosphatase Activity nor Phosphoinositide Levels in Rat Brain , 1989, Journal of neurochemistry.

[67]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[68]  I. Kapetanovic,et al.  Effects of pharmacological manipulations on basal and newly synthesized levels of GABA, glutamate, aspartate and glutamine in mouse brain cortex. , 1988, Biochemical pharmacology.

[69]  P. Renshaw,et al.  Chronic dietary lithium induces increased levels of myo-inositol-1-phosphatase activity in rat cerebral cortex homogenates , 1986, Brain Research.

[70]  J. Nurnberger,et al.  Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. , 1983, Biological psychiatry.

[71]  A. Lajtha,et al.  Lithium: Effect on [3H]spiperone binding, ionic content, and amino acid levels in the brain of rats , 1982, Neurochemical Research.

[72]  P. Patsalos,et al.  Changes in Regional Brain Levels of Amino Acid Putative Neurotransmitters After Prolonged Treatment with t he Anticonvulsant Drugs Diphenylhydantoin, Phenobarbitone, Sodium Valproate, Ethosuximide, and Sulthiame in the Rat , 1981, Journal of neurochemistry.

[73]  W. Sherman,et al.  The Effects of Lithium on myo‐Inositol Levels in Layers of Frontal Cerebral Cortex, in Cerebellum, and in Corpus Callosum of the Rat , 1980, Journal of neurochemistry.

[74]  R. Guynn,et al.  The effect of the combination of lithium and haloperidol on brain intermediary metabolism in vivo , 1979, Psychopharmacology.

[75]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[76]  J. Mendels,et al.  The prediction of brain lithium concentrations from plasma or erythrocyte measures. , 1973, Journal of psychiatric research.

[77]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[78]  G. Rosenberg,et al.  Magnetic Resonance Spectroscopy , 2021, Encyclopedia of Autism Spectrum Disorders.

[79]  J. Jaeken,et al.  Valproate increases cerebrospinal fluid glutamine levels , 2004, European Journal of Pediatrics.

[80]  S. Posse,et al.  Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. , 1999, Archives of general psychiatry.

[81]  N. Kato,et al.  Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[82]  N. Kato,et al.  Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[83]  T. Inubushi,et al.  Effect of photic stimulation on energy metabolism in the human brain measured by 31P-MR spectroscopy. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[84]  T. Inubushi,et al.  Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. , 1993, Journal of affective disorders.